U.S. Chamber comments on the Centers for Medicare & Medicaid Services' ("CMS's") Draft Guidance implementing Initial Price Applicability Year 2028 ("IPAY 2028") of the Medicare Drug Price Negotiation Program created by the Biden Administration under the Inflation Reduction Act ("IRA").
Recommended
- Health Care
Breast Cancer's $25 Trillion Miracle—and Why It's at Risk
Decades of U.S. medical innovation have cut breast cancer deaths by 44% and generated $25 trillion in health and economic value, but proposed foreign price controls risk undermining the research pipeline that made these gains possible.
By Kelly Anderson
- Intellectual Property
The Global Fight for IP Protection Is Changing Fast
By Kelly Anderson
View this online
